Kung-Chao Chang Selected Research

Kung-Chao Chang Research Topics

Disease

22	Neoplasms (Cancer) 07/2022 - 07/2005
8	Lymphoma (Lymphomas) 11/2022 - 12/2008
5	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2011
4	Hodgkin Disease (Hodgkin's Disease) 11/2021 - 07/2009
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2011
4	Carcinogenesis 01/2018 - 01/2013
4	Infections 10/2016 - 05/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016 - 02/2006
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 04/2010
3	Hepatocellular Carcinoma (Hepatoma) 10/2017 - 01/2012
3	Nasopharyngeal Carcinoma 06/2012 - 05/2009
2	Inflammation (Inflammations) 02/2021 - 09/2014
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2019 - 01/2015
2	Fibrosis (Cirrhosis) 01/2018 - 01/2012
2	Mouth Neoplasms (Oral Cancer) 09/2015 - 01/2014
2	Myocardial Infarction 03/2014 - 09/2010
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2022
1	Drug Hypersensitivity Syndrome 01/2022
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2022
1	Hemolytic Anemia 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Eosinophilia 01/2022
1	Enteropathy-Associated T-Cell Lymphoma 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Sclerosis 11/2021
1	Lymphadenopathy 11/2021
1	Starvation 04/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Histiocytic Necrotizing Lymphadenitis (Kikuchi Disease) 10/2019
1	Lymphadenitis (Adenitis) 10/2019
1	Epstein-Barr Virus Infections 01/2017
1	Immunoglobulin G4-Related Disease 10/2016
1	Dengue (Dengue Fever) 10/2016
1	Plasma Cell Granuloma 10/2016
1	Thymoma (Thymic Carcinoma) 12/2015
1	Adenocarcinoma 11/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Genomic Instability 09/2014
1	Chronic Hepatitis B 09/2014
1	Hematologic Neoplasms (Hematological Malignancy) 08/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2014
1	Polyploidy 08/2014

Drug/Important Bio-Agent (IBA)

4	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 04/2010
4	Oncogene Proteins (Oncogene Protein)IBA 11/2015 - 05/2009
3	Messenger RNA (mRNA)IBA 01/2020 - 10/2011
3	Immunoglobulin G (IgG)IBA 01/2018 - 10/2016
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
2	interleukin 20 (IL-20)IBA 02/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2012
2	Immunoglobulin M (IgM)IBA 08/2019 - 10/2016
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2018 - 12/2017
2	Granzymes (Granzyme)IBA 11/2015 - 11/2007
2	HLA-DR Antigens (HLA-DR)IBA 11/2015 - 11/2007
2	Androgen Receptors (Androgen Receptor)IBA 06/2014 - 08/2010
2	MicroRNAs (MicroRNA)IBA 01/2014 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 01/2013 - 01/2012
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2022
1	5- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA 01/2022
1	InterferonsIBA 11/2021
1	AutoantibodiesIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2021
1	AntioxidantsIBA 02/2021
1	interleukin-24 (ST16)IBA 02/2021
1	AgarIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	RNA IsoformsIBA 01/2020
1	locked nucleic acidIBA 01/2020
1	Phenytoin (Dilantin)FDA LinkGeneric 10/2019
1	ParaproteinsIBA 08/2019
1	FibrinIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Trans-Activators (Trans-Acting Factor)IBA 12/2017
1	NucleotidesIBA 10/2017
1	CytokinesIBA 01/2017
1	Interleukin-13IBA 01/2017
1	AntibodiesIBA 10/2016
1	AntigensIBA 10/2016
1	ON 01910IBA 01/2016
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 11/2015
1	Indicators and Reagents (Reagents)IBA 11/2015
1	Complementary DNA (cDNA)IBA 11/2015
1	Lysosomal Membrane ProteinsIBA 11/2015
1	Calcium-Binding ProteinsIBA 09/2015
1	Calgranulin BIBA 09/2015
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2015
1	7-hydroxy-6-methoxyphthalide (MA-1)IBA 01/2015
1	Surface Antigens (Surface Antigen)IBA 09/2014
1	Viral ProteinsIBA 09/2014
1	Aurora KinasesIBA 08/2014
1	Aurora Kinase AIBA 08/2014

Therapy/Procedure

10	Therapeutics 11/2022 - 09/2010
2	Drug Therapy (Chemotherapy) 11/2022 - 12/2015
1	Splenectomy 10/2016
1	Chemoradiotherapy 12/2015
1	Adjuvant Chemoradiotherapy 11/2015